Fundraising Fox

Spectrumai

Acquired

Founded 2021 Β· 12 employees on LinkedIn Β· 8 known investors

SpectrumAi builds data analytics and AI-based software for Applied Behavior Analysis (ABA) providers, serving BCBAs and behavior technicians as well as payors. Its tools support in-session data collection, session video review, program modification, and network performance analytics for autism care organizations of all sizes.

Also known as Spectrum Ai Β· SpectrumAi

Founders & leadership

Spectrumai was founded in 2021 by Ling Shao.

LSLing Shao
Ling ShaoinFounder & CEO
JAJoseph Adu
Joseph AduinChief Technology Officer
LHLiz Hevenstone
Liz HevenstoneinChief Commercial Officer

Investors Β· 8

Also in the syndicate Β· 3

Autism Impact FundF-PrimeKent Marquardt

Company profile

researched Aug 2026

SpectrumAi is a Los Angeles, California-based digital health company focused on modernizing Applied Behavior Analysis (ABA) therapy for children with autism spectrum disorder (ASD). Its products capture objective treatment and outcomes data at the point of care so that quality drivers in ABA can be measured. The core product, Twyll, is an ABA-specific electronic health record and data-collection application built for Board Certified Behavior Analysts (BCBAs) and behavior technicians (BTs), with in-session data collection, session video recording and review, real-time graphing and program modification, audit-ready reporting, a curriculum builder, an integration layer called Zipper for connecting to practice management, scheduling and CRM systems, and Twyll Academy, a learning management system for user training.

A companion product, Patterns, provides ABA network performance analytics aimed at payors and turns collected documentation into interactive data visualizations of progress and outcomes. Twyll is optimized for tablets but runs on smartphones as well, operates offline, and is hosted across multiple AWS availability zones with real-time database replication, cross-region backups and 24/7 monitoring. The company positions the software for organizations ranging from solo practitioners and boutique practices to enterprise-sized ABA provider groups, with pricing plans that vary by organization size.

SpectrumAi was founded in 2021 and was acquired by CentralReach in 2025.

Founding story

SpectrumAi was founded in 2021 by Ling Shao, who had worked in healthcare as a nurse and later as a payor executive and healthcare leader. After her son was diagnosed with ASD, she used her professional network to access experienced ABA providers, including moving her family to the west coast. With additional children later diagnosed with ASD β€” she is the parent of four autistic sons β€” she concluded that consolidating provider data and generating analytic insights required a purpose-built clinical documentation solution, and began building SpectrumAi to give ABA providers a consumer-grade way to collect data at the moment of care. Press coverage describes Shao as co-founder and CEO alongside co-founders Elizabeth Bigham (chief operating officer) and Chris Storer (chief marketing officer).

Business model

SpectrumAi licenses its software to ABA provider organizations, offering flexible pricing plans scaled to the size of the practice, from solo practitioners to large ABA organizations. It also works with payers who seek access to aggregate data generated by SpectrumAi users, with the stated aim of supporting value-based care adoption in ABA therapy and ASD treatment.

Software sold to ABA provider organizations under pricing plans tailored to provider size, alongside a payer-facing analytics product (Patterns) that measures ABA network performance.

Traction

Publicly reported traction is limited to investor and customer signals: backing from CVS Health Ventures, F-Prime Capital, Frist Cressey Ventures, Cobalt Ventures and the Autism Impact Fund; a testimonial from the chief clinical officer of provider organization LEARN Behavioral; and the 2025 acquisition by CentralReach.

Latest developments

SpectrumAi was acquired by CentralReach in 2025; the deal was announced in August 2025, with Goodwin advising SpectrumAi.

β–ΈFull profile β€” market position, technology, go-to-market, geography, history, risks & controversies

Market position

SpectrumAi positioned itself against a shortage of technological innovation and of universally accepted objective data standards for care quality and outcomes in ABA, a therapy that all 50 states require health plans to cover at some level. Other organizations, including the Behavioral Health Center of Excellence with Evernorth and Centene, have worked on ABA quality measures and benchmarks, and other companies address autism care from adjacent angles, such as Brightline in pediatric behavioral health and Mightier's gamified platform.

The company focuses exclusively on tooling for BCBAs and behavior technicians rather than general practice management, pairing point-of-care data collection in Twyll with a payer-facing network analytics product, Patterns, so that the same objective documentation supports clinical supervision, audit response and reimbursement aligned to outcomes. Distinguishing features include session video capture with highlight review, offline-capable tablet data collection, and the Zipper interoperability layer.

Technology

Twyll is a mobile-first ABA electronic health record optimized for tablets and compatible with smartphones, with offline operation for uninterrupted documentation, video capture of sessions for later review and supervision, real-time graphing for on-the-fly program modification, and audit-ready report generation. Zipper provides integration and interoperability with practice management, scheduling and CRM systems. The platform is hosted across multiple AWS availability zones with real-time database replication, failover, geographically replicated and tested backups, and 24/7 monitoring. The company describes combining data analytics and AI technology with traditional ABA methodologies, and Patterns applies analytics and data visualization to aggregated provider data.

Go-to-market

Direct sales to ABA provider organizations with onboarding support, including a self-serve curriculum builder for small practices and a dedicated implementation team that imports curricula from incumbent systems for larger practices; content marketing aimed at BCBAs; and a parallel payer channel through the Patterns network analytics product. The company cites customer endorsement from LEARN Behavioral, whose chief clinical officer Hannah Rue is quoted on its site.

ABA therapy provider organizations of all sizes β€” from solo practitioners and boutique practices to enterprise ABA groups β€” and their BCBAs and behavior technicians, plus health plans, payers and employers seeking objective data on ABA care quality and outcomes.

Geography

Headquartered in Los Angeles, California, serving families and ABA providers across the United States.

History

Founded in 2021 and based in Los Angeles, SpectrumAi received an investment from the Autism Impact Fund announced in December 2021, then raised $9 million in seed funding announced in June 2022, co-led by F-Prime Capital and Frist Cressey Ventures. F-Prime records its initial investment in 2022. The company subsequently raised up to $20 million in Series A funding led by CVS Health Ventures, with the proceeds earmarked for accelerating adoption of Twyll and Patterns. In 2025 SpectrumAi was acquired by CentralReach; the transaction was announced by the company's legal adviser Goodwin in August 2025.

Risks & controversies

The company itself notes that ABA therapy quality varies dramatically and that, used poorly, ABA can be harmful, and that the field lacks universally accepted objective data standards for care quality and outcomes β€” the premise on which its measurement products depend.

Compiled by commissioned research from 8 cited public sources β€” announcements, filings, and press listed under research sources below.

Competitors Β· 2

by search overlap

Companies competing with Spectrumai for the same Google search keywords, organic and paid, via search-intersection analysis.

Timeline Β· 4

launches, deals, and filings
Aug 2025
SpectrumAi acquired by CentralReach

SpectrumAi was acquired by CentralReach; Goodwin's digital health team advised SpectrumAi on the transaction, announced August 21, 2025. F-Prime lists the acquisition as occurring in 2025.

source β†—

Jan 2023
SpectrumAi raises up to $20M Series A

Series A funding led by CVS Health Ventures with participation from Cobalt Ventures, F-Prime, Frist Cressey and Autism Impact Fund, to accelerate adoption of Twyll and Patterns.

$20M source β†—

Jun 2022
SpectrumAi raises $9M seed round

Seed funding co-led by F-Prime Capital and Frist Cressey Ventures, with participation from the Autism Impact Fund and Kent Marquardt, former CFO of Premera Blue Cross.

$9M source β†—

Dec 2021
Autism Impact Fund announces investment in SpectrumAi

The Autism Impact Fund announced an investment in SpectrumAi in December, ahead of the company's seed round.

source β†—

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

β–ΈResearch sources Β· 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Spectrumai do?
SpectrumAi builds ABA therapy documentation and analytics software for autism providers and payers; acquired by CentralReach in 2025.
Who founded Spectrumai?
Spectrumai was founded by Ling Shao in 2021.
Who are Spectrumai's investors?
Spectrumai's investors include Frist Cressey Ventures, AIF, Cobalt Ventures, CVS Health Ventures, F-Prime Capital.